Anil Kumar Pillai MD, Presenter: Nothing to Disclose

Jed Alan Hummel MD, Abstract Co-Author: Nothing to Disclose

Sanjeeva P. Kalva MD, Abstract Co-Author: Proctor, Sirtex Medical Ltd Consultant, Celonova Biosciences Inc

Seth Toomay MD, Abstract Co-Author: Nothing to Disclose

Mark Reddick, Abstract Co-Author: Nothing to Disclose

Nancy Katherine Rollins MD, Abstract Co-Author: Nothing to Disclose

Kenrick Lam BS, Abstract Co-Author: Nothing to Disclose

• To discuss the classification and imaging features of peripheral AVMs. • To discuss the factors that affect the selection of an embolic material during endovascular therapy • To discuss the techniques employed in the management of high flow AVMs. • To present our experience of different embolic materials used in the endovascular treatment of peripheral high flow AVMs.

This presentation will include classification, imaging features on CT/MRI and catheter angiography, anatomical and flow considerations in the selection of the embolic materials, the technical aspects and a brief review of literature eliciting the success rates of such therapy. The role of various embolic materials including alcohol, 3% sotradecol, n-butyl cyanoacrylate, ethylene vinyl copolymer, coils and vascular plug devices will be illustrated.

The high flow AVM are often associated with serious symptoms. The endovascular management of vascular malformations is gaining acceptance as the primary treatment. The viewer will gain a better understanding of classification, indications and contraindications for endovascular therapy, technical considerations, different embolic materials and complications following endovascular therapy of high flow peripheral

Pillai, A, Hummel, J, Kalva, S, Toomay, S, Reddick, M, Rollins, N, Lam, K, Diagnosis and Endovascular Management of High Flow Peripheral Arterio-venous Malformations (AVMs).  Radiological Society of North America 2013 Scientific Assembly and Annual Meeting, December 1 - December 6, 2013 ,Chicago IL. http://archive.rsna.org/2013/13016273.html